Your browser doesn't support javascript.
loading
Serum and cerebrospinal fluid cytokines in children with acute encephalopathy.
Kawahara, Yuta; Morimoto, Akira; Oh, Yukiko; Furukawa, Rieko; Wakabayashi, Kei; Monden, Yukifumi; Osaka, Hitoshi; Yamagata, Takanori.
Affiliation
  • Kawahara Y; Department of Pediatrics, Jichi Medical University School of Medicine, Japan. Electronic address: r0716yk@jichi.ac.jp.
  • Morimoto A; Department of Pediatrics, Jichi Medical University School of Medicine, Japan.
  • Oh Y; Department of Pediatrics, Jichi Medical University School of Medicine, Japan.
  • Furukawa R; Department of Pediatric Medical Imaging, Jichi Medical University School of Medicine, Japan.
  • Wakabayashi K; Department of Pediatrics, Jichi Medical University School of Medicine, Japan.
  • Monden Y; Department of Pediatrics, Jichi Medical University School of Medicine, Japan; Department of Pediatrics, International University of Health and Welfare, Japan.
  • Osaka H; Department of Pediatrics, Jichi Medical University School of Medicine, Japan.
  • Yamagata T; Department of Pediatrics, Jichi Medical University School of Medicine, Japan.
Brain Dev ; 42(2): 185-191, 2020 Feb.
Article in En | MEDLINE | ID: mdl-31787380
ABSTRACT

BACKGROUND:

The pathogenesis of acute encephalopathy (AE) remains unclear, and a biomarker has not been identified.

METHODS:

Levels of 49 cytokines and chemokines, including osteopontin (OPN), were measured in serum and cerebrospinal fluid (CSF) of children with AE (n = 17) or febrile convulsion (FC; n = 8; control group). The AE group included acute necrotizing encephalopathy (n = 1), acute encephalopathy with biphasic seizures and late reduced diffusion (AESD; n = 3), clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS; n = 4), and unclassified acute encephalopathy (UCAE; n = 9) that does not meet the criteria of syndrome classification. Five individuals with AE had neurological sequelae or death (poor prognosis), whereas 12 were alive without neurological sequelae (good prognosis).

RESULTS:

The CSFserum ratios of OPN, CC chemokine ligand (CCL)4, and interleukin (IL)-10 were significantly higher in AE than in FC. The CSF levels of macrophage inhibitory factor (MIF) and leukemia inhibitory factor (LIF) were significantly higher in the poor-prognosis group than in the good-prognosis group. The CSFserum ratios of OPN were significantly higher in AESD and in MERS than in FC. The CSFserum ratios of MIF and OPN were higher in MERS than in UCAE or FC.

CONCLUSION:

Our results suggest that microglia-related cytokines and chemokines such as OPN, MIF, and LIF could be novel biomarkers of AE, in addition to the previously reported IL-10 and CCL4, and that MIF and LIF may be markers of poor prognosis.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Diseases / Cytokines Type of study: Etiology_studies / Prognostic_studies Limits: Child, preschool / Female / Humans / Infant / Male Language: En Journal: Brain Dev Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Diseases / Cytokines Type of study: Etiology_studies / Prognostic_studies Limits: Child, preschool / Female / Humans / Infant / Male Language: En Journal: Brain Dev Year: 2020 Document type: Article